AtriCure CTO sells 7,763 shares at $52.50

AtriCure’s chief technical officer executed a pre-planned Rule 10b5-1 sale of 7,763 shares, remaining a significant shareholder.

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) reported that Chief Technical Officer Salvatore Privitera sold 7,763 shares of common stock on September 2, 2026 at a price of $52.50 per share in an open-market or private transaction. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2026. After this transaction, he held 150,921 shares of AtriCure common stock directly.

Insider Trade Summary 10b5-1

Net Seller: 7,763 shares

Net Sell 1 txn

Insider Privitera Salvatore

Role Chief Technical Officer

Sold 7,763 shs ($408K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	7,763	$52.50	$408K

Holdings After Transaction: Common Stock — 150,921 shares (Direct)

Footnotes (1)

1. F1. These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.

Key Figures

Shares sold: 7,763 shares Sale price per share: $52.50 per share Shares held after transaction: 150,921 shares +2 more

5 metrics

Shares sold 7,763 shares Common stock sale reported for September 2, 2026

Sale price per share $52.50 per share Price for the 7,763 shares sold on September 2, 2026

Shares held after transaction 150,921 shares Direct holdings of Salvatore Privitera after the sale

Rule 10b5-1 plan adoption date February 20, 2026 Adoption date of the trading plan governing the reported sale

Net shares sold in filing 7,763 shares Net selling activity across all reported transactions in this Form 4

Key Terms

Rule 10b5-1 trading plan, open-market or private transaction, common stock

3 terms

Rule 10b5-1 trading plan regulatory

"These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market or private transaction financial

"Sale in open market or private transaction"

common stock financial

"These shares were sold pursuant to a 10b5-1 trading plan"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AtriCure (ATRC) disclose in this Form 4?

AtriCure disclosed that Chief Technical Officer Salvatore Privitera sold 7,763 shares of common stock on September 2, 2026 at $52.50 per share in an open-market or private transaction.

How many AtriCure (ATRC) shares does the insider hold after this sale?

After the reported transaction, Chief Technical Officer Salvatore Privitera directly held 150,921 shares of AtriCure common stock.

Was the AtriCure (ATRC) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states that the 7,763-share sale on September 2, 2026 was made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2026.

What price did the AtriCure (ATRC) insider receive per share in the sale?

The reported sale by Chief Technical Officer Salvatore Privitera was executed at a price of $52.50 per share for 7,763 shares of AtriCure common stock.

Which AtriCure (ATRC) executive reported this Form 4 transaction?

The Form 4 transaction was reported by Salvatore Privitera, who serves as Chief Technical Officer of AtriCure, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 07:39 AM EDT Accepted by SEC EDGAR 09/04/2026 - 07:39 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Privitera Salvatore

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OHIO 45040-9695

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2026		S		7,763(1)	D	$52.5	150,921	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.

Remarks:

	/s/ Salvatore Privitera	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)